When hepatic steatosis develops, HSCs are activated and express several fibrosis markers such as transforming growth factor β, tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2), and matrix metalloproteinase-2 (57). This evidence concerns the gene TIMP1 and fatty liver disease.